Tracking bleeding risk during ECMO support
Part of Blood & lymphatic clinical trials.
This study looks at whether a blood test called D-dimer can help predict bleeding in patients on ECMO, a machine that helps the heart or lungs. It aims to improve safety by monitoring this marker.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in an intensive care unit.
- You have been on ECMO for less than 24 hours.
- You are not pregnant or breastfeeding.
- You are not on ECMO after heart surgery or with a heart assist device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how doctors can monitor your blood flow and fluid needs while you are on VV-ECMO. It involves a simple maneuver where your legs are raised to see if your heart needs more fluid.
This study tests whether adding a medicine called prostacyclin (which helps keep blood from clotting) to the standard blood thinner can help children on ECMO—a machine that takes over heart and lung function—have fewer clotting problems and bleeding issues.
This trial tests a way to manage blood clotting in patients on ECMO (a machine that helps breathe for very sick patients). It uses a drug called Nafamostat with a lower dose of standard blood thinners, which may reduce bleeding risks.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This trial tests whether a medication called recombinant von Willebrand factor (vWF) can help control major bleeding in adults who are on life support with ECMO. If you are on ECMO and have a serious bleed, this treatment might help stop the bleeding.
This study is testing a new D-dimer blood test (AQT90 FLEX) to see how well it detects blood clots in people who have symptoms but a low to moderate risk. If you join, this test may help rule out dangerous clots more quickly.
Hear when a new ECMO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.